| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
48,386 |
48,100 |
$12.24M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
66,610 |
66,205 |
$11.63M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
11,338 |
11,262 |
$4.08M |
| J0791 |
Injection, crizanlizumab-tmca, 5 mg |
774 |
568 |
$2.50M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
13,280 |
6,678 |
$1.38M |
| D9999 |
Unspecified adjunctive procedure, by report |
1,370 |
1,370 |
$1.18M |
| 87631 |
|
8,926 |
8,906 |
$1.11M |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
15,318 |
15,262 |
$922K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
882 |
882 |
$634K |
| 80053 |
Comprehensive metabolic panel |
50,004 |
43,670 |
$606K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
1,185 |
1,185 |
$567K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
13,162 |
4,544 |
$462K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
57,856 |
48,634 |
$395K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
1,844 |
966 |
$383K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
55,759 |
50,761 |
$372K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
9,731 |
4,416 |
$370K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
99 |
99 |
$348K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,286 |
1,281 |
$344K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,447 |
3,426 |
$332K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
9,338 |
9,310 |
$282K |
| 71046 |
Radiologic examination, chest; 2 views |
12,225 |
12,111 |
$244K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,623 |
1,619 |
$237K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
627 |
626 |
$222K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,366 |
2,359 |
$190K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,471 |
1,237 |
$132K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
720 |
717 |
$123K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
8,494 |
8,461 |
$119K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,838 |
1,692 |
$115K |
| 71045 |
Radiologic examination, chest; single view |
8,332 |
8,262 |
$101K |
| 81001 |
|
16,716 |
16,620 |
$78K |
| 92526 |
|
1,008 |
407 |
$75K |
| 99205 |
Prolong outpt/office vis |
451 |
451 |
$70K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,360 |
1,352 |
$65K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
10,521 |
10,315 |
$63K |
| 83615 |
|
10,279 |
5,318 |
$56K |
| 84703 |
|
7,668 |
7,588 |
$55K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
262 |
262 |
$51K |
| 87486 |
|
1,617 |
1,613 |
$50K |
| 87581 |
|
1,617 |
1,613 |
$49K |
| 87807 |
|
4,066 |
4,054 |
$48K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
858 |
853 |
$47K |
| 84100 |
|
10,312 |
5,331 |
$44K |
| 84550 |
|
10,269 |
5,309 |
$41K |
| 83735 |
|
6,828 |
3,644 |
$40K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,587 |
2,204 |
$38K |
| 95886 |
|
460 |
460 |
$36K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
714 |
713 |
$35K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,487 |
1,482 |
$34K |
| 36415 |
Collection of venous blood by venipuncture |
6,215 |
5,449 |
$34K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
512 |
508 |
$27K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
630 |
268 |
$27K |
| 95819 |
|
97 |
97 |
$26K |
| 74019 |
|
1,200 |
1,196 |
$24K |
| 36430 |
|
149 |
121 |
$22K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,998 |
2,995 |
$22K |
| 82962 |
|
4,498 |
3,890 |
$22K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
27 |
27 |
$21K |
| 20680 |
|
13 |
12 |
$21K |
| 84484 |
|
1,942 |
1,420 |
$20K |
| 99222 |
Initial hospital care, per day, moderate complexity |
228 |
215 |
$18K |
| 83690 |
|
2,659 |
2,629 |
$17K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
314 |
314 |
$16K |
| 31624 |
|
14 |
14 |
$15K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
146 |
119 |
$14K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
111 |
111 |
$13K |
| 73630 |
|
601 |
592 |
$13K |
| 76801 |
|
204 |
204 |
$12K |
| 99215 |
Prolong outpt/office vis |
97 |
97 |
$12K |
| 74230 |
|
135 |
135 |
$11K |
| 95816 |
|
49 |
49 |
$11K |
| 87430 |
|
722 |
721 |
$10K |
| 95910 |
|
199 |
199 |
$8K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
14 |
14 |
$8K |
| 95782 |
|
12 |
12 |
$8K |
| 95908 |
|
253 |
253 |
$8K |
| 87070 |
|
753 |
752 |
$6K |
| 99223 |
Prolong inpt eval add15 m |
49 |
44 |
$5K |
| 83880 |
|
169 |
166 |
$5K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
72 |
72 |
$5K |
| 96523 |
|
127 |
109 |
$5K |
| 99233 |
Prolong inpt eval add15 m |
49 |
17 |
$5K |
| 62323 |
|
12 |
12 |
$4K |
| 86140 |
|
981 |
957 |
$4K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
528 |
503 |
$4K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
53 |
53 |
$4K |
| 85045 |
|
958 |
874 |
$3K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
3,465 |
3,391 |
$3K |
| 81025 |
|
373 |
370 |
$3K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,724 |
997 |
$2K |
| 88312 |
|
29 |
29 |
$2K |
| 80143 |
|
141 |
138 |
$2K |
| 80179 |
|
141 |
138 |
$2K |
| 82550 |
|
319 |
305 |
$2K |
| 82565 |
|
325 |
325 |
$2K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
15 |
15 |
$1K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
3,470 |
2,875 |
$1K |
| 74018 |
|
88 |
85 |
$1K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
12 |
12 |
$1K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
12 |
12 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
83 |
83 |
$1K |
| 99201 |
|
39 |
39 |
$1K |
| 88313 |
|
14 |
14 |
$963.20 |
| 82657 |
|
56 |
56 |
$958.72 |
| 87077 |
|
108 |
108 |
$873.71 |
| 91065 |
|
12 |
12 |
$740.76 |
| 82784 |
|
77 |
65 |
$700.87 |
| 88112 |
|
14 |
14 |
$693.12 |
| 83605 |
|
53 |
44 |
$524.79 |
| 93296 |
|
60 |
60 |
$471.74 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
1,162 |
617 |
$455.95 |
| 86850 |
|
45 |
25 |
$384.49 |
| 82728 |
|
34 |
34 |
$363.60 |
| 84466 |
|
33 |
33 |
$329.15 |
| 86901 |
|
114 |
94 |
$287.02 |
| 73090 |
|
12 |
12 |
$273.60 |
| 90688 |
|
16 |
16 |
$267.60 |
| 85060 |
|
12 |
12 |
$264.72 |
| 85652 |
|
84 |
79 |
$196.80 |
| 82800 |
|
18 |
18 |
$176.04 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
6,282 |
6,210 |
$167.97 |
| 83540 |
|
33 |
33 |
$166.75 |
| 86900 |
|
57 |
37 |
$148.70 |
| 80061 |
Lipid panel |
15 |
15 |
$133.30 |
| 87040 |
|
13 |
13 |
$119.34 |
| 87116 |
|
14 |
14 |
$115.32 |
| 87186 |
|
12 |
12 |
$114.14 |
| 85379 |
|
12 |
12 |
$108.60 |
| 87102 |
|
14 |
14 |
$89.76 |
| 36591 |
|
37 |
25 |
$71.01 |
| 87206 |
|
14 |
14 |
$62.27 |
| 85610 |
|
12 |
12 |
$49.66 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
277 |
276 |
$21.89 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
14 |
14 |
$20.30 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
897 |
276 |
$10.95 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
581 |
496 |
$3.36 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
666 |
665 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
121 |
120 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
80 |
80 |
$0.00 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
13 |
13 |
$0.00 |
| C1889 |
Implantable/insertable device, not otherwise classified |
121 |
121 |
$0.00 |
| 96376 |
|
139 |
126 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
12 |
12 |
$0.00 |
| 92611 |
|
126 |
126 |
$0.00 |
| J9260 |
Injection, methotrexate sodium, 50 mg |
45 |
24 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,201 |
173 |
$0.00 |
| 99152 |
|
80 |
80 |
$0.00 |
| J9370 |
Vincristine sulfate, 1 mg |
187 |
139 |
$0.00 |